Insulet
PODD
#1335
Rank
NZ$28.98 B
Marketcap
NZ$411.76
Share price
-1.72%
Change (1 day)
-16.46%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2025 (TTM): NZ$6.10

According to Insulet's latest financial reports the company's current EPS (TTM) is NZ$5.88. In 2024 the company made an earnings per share (EPS) of NZ$10.05 an increase over its 2023 EPS that were of NZ$4.96.

EPS history for Insulet from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$6.10-39.29%
2024NZ$10.05102.71%
2023NZ$4.964114.29%
2022NZ$0.12-69.57%
2021NZ$0.39109.09%
2020NZ$0.18-38.89%
2019NZ$0.30200%
2018NZ$0.10-113.04%
2017NZ-$0.77-9.8%
2016NZ-$0.86-60.47%
2015NZ-$2.1738.71%
2014NZ-$1.5612.05%
2013NZ-$1.39-23.15%
2012NZ-$1.81-12.2%
2011NZ-$2.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.71 218.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.30 7.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.23 6.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$38.68 557.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
NZ-$5.12-187.14%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ-$0.52-108.86%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$3.11-47.14%๐Ÿ‡บ๐Ÿ‡ธ USA